Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1989 1
1995 1
1997 1
1998 4
1999 5
2000 5
2001 4
2002 5
2003 3
2004 5
2005 3
2006 3
2007 7
2008 4
2009 9
2010 7
2011 13
2012 13
2013 11
2014 8
2015 14
2016 18
2017 17
2018 12
2019 8
2020 23
2021 23
2022 31
2023 37
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention.
Lee SH, Jeong YH, Hong D, Choi KH, Lee JM, Park TK, Yang JH, Hahn JY, Choi SH, Gwon HC, Jeong MH, Kim BK, Joo HJ, Chang K, Park Y, Ahn SG, Suh JW, Lee SY, Cho JR, Her AY, Kim HS, Kim MH, Lim DS, Shin ES, Song YB; PTRG-DES Registry Investigators. Lee SH, et al. Among authors: joo hj. JACC Cardiovasc Interv. 2023 Apr 10;16(7):829-843. doi: 10.1016/j.jcin.2023.01.363. Epub 2023 Mar 8. JACC Cardiovasc Interv. 2023. PMID: 37045504 Free article.
LY6K depletion modulates TGF-β and EGF signaling.
Park S, Park D, Han S, Chung GE, Soh S, Ka HI, Joo HJ, Yang Y. Park S, et al. Among authors: joo hj. Cancer Med. 2023 Jun;12(11):12593-12607. doi: 10.1002/cam4.5940. Epub 2023 Apr 19. Cancer Med. 2023. PMID: 37076981 Free PMC article.
Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
Cha JJ, Hong SJ, Kim JH, Lim S, Joo HJ, Park JH, Yu CW, Lee PH, Lee SW, Lee CW, Moon JY, Lee JY, Kim JS, Park JS, Lee K, Lim SY, Na JO, Cho JM, Kim SY, Lim DS. Cha JJ, et al. Among authors: joo hj. Am Heart J. 2023 Jul;261:45-50. doi: 10.1016/j.ahj.2023.03.002. Epub 2023 Mar 17. Am Heart J. 2023. PMID: 36934981 Clinical Trial.
Infantile myofibromatosis.
Kim KH, Park YN, Joo HJ, Lee KG, Park C, Kim DS. Kim KH, et al. Among authors: joo hj. Yonsei Med J. 1989 Dec;30(4):376-82. doi: 10.3349/ymj.1989.30.4.376. Yonsei Med J. 1989. PMID: 2626841 Free article.
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium.
Lee SJ, Cha JJ, Jeong YH, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Joo HJ, Chang K, Park Y, Song YB, Ahn SG, Suh JW, Lee SY, Cho JR, Her AY, Kim HS, Kim MH, Shin ES, Lim DS, Kim BK; PTRG Investigators. Lee SJ, et al. Among authors: joo hj. JACC Cardiovasc Interv. 2022 Nov 28;15(22):2253-2265. doi: 10.1016/j.jcin.2022.09.007. JACC Cardiovasc Interv. 2022. PMID: 36423968 Free article.
Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock.
Jeong JH, Kook H, Lee SH, Joo HJ, Park JH, Hong SJ, Kim MN, Park SM, Jung JS, Yang JH, Gwon HC, Ahn CM, Jang WJ, Kim HJ, Bae JW, Kwon SU, Lee WS, Jeong JO, Park SD, Lim SH, Yu CW. Jeong JH, et al. Among authors: joo hj. Sci Rep. 2023 Oct 16;13(1):17529. doi: 10.1038/s41598-023-44679-2. Sci Rep. 2023. PMID: 37845266 Free PMC article.
285 results